Overall, we concluded that the anti-obesity effects of PNS were mediated by leptin activation induced by changes in the gut microbiota, and this finding offers new insights into the microbiota-mediated regulation of beige fat and provides a novel anti-obese therapeutic strategy involving modulation of the gut microbiota. The gene discussed is LEP; the disease is obesity disorder.